Effect of supplementation in treatment of women with gestational diabetes

Phase 3

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; O24.9

• Registration Number: IRCT201704235623N111
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Patients with gestational diabetes
Aged 18 to 40 years

Exclusion Criteria

Taking magnesium supplements within the past 3 months
Needing to insulin therapy during the intervention
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of PPAR-?. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.;Expressed levels of GLUT-1. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Expressed levels of LDLR gene. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.;Expressed levels of Lp(a) gene. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR.